Access the full text.
Sign up today, get DeepDyve free for 14 days.
The Group (2017)
Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD studyDiabetologia, 60
B. Davies, F. Cramp, J. Gauntlett-Gilbert, D. Wynick, C. McCabe (2015)
The role of physical activity and psychological coping strategies in the management of painful diabetic neuropathy--A systematic review of the literature.Physiotherapy, 101 4
B. Callaghan, Evan Reynolds, M. Banerjee, K. Kerber, Lesli Skolarus, J. Burke (2018)
Longitudinal pattern of pain medication utilization in peripheral neuropathy patientsPAIN, 160
B. Callaghan, K. Kerber, Lynda Lisabeth, L. Morgenstern, R. Longoria, A. Rodgers, P. Longwell, E. Feldman (2014)
Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy.JAMA neurology, 71 9
D. Dowell, Tamara Haegerich, R. Chou (2016)
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.JAMA, 315 15
B. Callaghan, Evan Reynolds, M. Banerjee, K. Kerber, Lesli Skolarus, Brandon Magliocco, G. Esper, J. Burke (2019)
Out-of-pocket costs are on the rise for commonly prescribed neurologic medicationsNeurology, 92
B. Callaghan, R. Price, E. Feldman (2015)
Distal Symmetric Polyneuropathy: A Review.JAMA, 314 20
N. Finnerup, N. Attal, S. Haroutounian, E. McNicol, R. Baron, R. Dworkin, I. Gilron, M. Haanpää, P. Hansson, T. Jensen, P. Kamerman, K. Lund, A. Moore, S. Raja, A. Rice, M. Rowbotham, E. Sena, P. Siddall, Blair Smith, M. Wallace (2015)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisThe Lancet Neurology, 14
B. Callaghan, R. Xia, Evan Reynolds, M. Banerjee, A. Rothberg, C. Burant, E. Villegas-Umana, R. Pop-Busui, E. Feldman (2016)
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.JAMA neurology, 73 12
B. Callaghan, R. Xia, Evan Reynolds, M. Banerjee, C. Burant, A. Rothberg, R. Pop-Busui, E. Villegas-Umana, E. Feldman (2018)
Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologistsClinical Neurophysiology, 129
This JAMA Insights Clinical Update reviews the diagnosis and management of distal symmetric neuropathy, including control of risk factors (eg, high glucose in type 1 diabetes, weight loss) and use of nonpharmacologic and pharmacologic therapies (eg, SNRIs, tricyclic antidepressants, gabapentinoids).
JAMA – American Medical Association
Published: Jul 7, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.